Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
  1. 4 Open-market buy Director bought 18,400 shares at an average $0.62 ($11,442)
  2. 4 Option exercise Director acquired 1,970,443 shares (option exercise)
  3. 4 Open-market buy Director bought 19,044 shares at $0.60 ($11,398)
  4. 4 Open-market buy Director bought 1,185,872 shares at an average $0.56 ($666,222)
  5. 4 Grant or award Director acquired 178,000 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 2,424,000 shares (grant or award)
  7. 4 Grant or award Chief Scientific Officer acquired 778,200 shares (grant or award)
  8. 4 Grant or award President and CEO acquired 4,654,100 shares (grant or award)
  9. 4 Grant or award Director acquired 178,000 shares (grant or award)
  10. 4 Grant or award Director acquired 178,000 shares (grant or award)
  11. 4 Grant or award Director acquired 178,000 shares (grant or award)
  12. 4 Grant or award Chief Medical Officer acquired 548,200 shares (grant or award)
  13. 4 Grant or award Director acquired 178,000 shares (grant or award)
  14. 4 Grant or award Director acquired 178,000 shares (grant or award)
  15. 4 Grant or award Director acquired 178,000 shares (grant or award)
  16. 4 Grant or award Director acquired 178,000 shares (grant or award)
  17. 4 Grant or award Chief Operating Officer acquired 1,531,000 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Returned to the company President and CEO returned 521,125 shares (to the company)

Page 5 of 21 · 410 filings